RT @cardiomet_CE: 22) The two big stroke secondary prevention trials that put dual antiplatelet therapy (#DAPT) on the map were CHANCE (🔓ht…
So far, Altmetric has seen
662 X posts from 552 X users, with an upper bound of 2,905,337 followers.
10,975 followers
4,185 followers
22) The two big stroke secondary prevention trials that put dual antiplatelet therapy (#DAPT) on the map were CHANCE (🔓https://t.co/M9Y4Dh392c) & POINT (🔓https://t.co/hQCiOpWqUI). Both est'd that a limited course of clopidogrel added to ASA after minor
153 followers
Guidelines: Asp+clopidogrel x 21 days in NIHSS ≤3 Clopidogrel+Asp vs Asp+Placebo: clopidogrel beneficial primary outcome (stroke/MI/death @ 90days) https://t.co/M8YLtsLfzr Ticagrelor vs Aspirin: no change in primary outcome (stroke/MI/death) https://t.co
2,043 followers
RT @RevEspCardiol: Ticagrelor not superior to aspirin in acute stroke or transient ischemic attack via @NEJM https://t.co/qAUNDAkHSp https:…